Aromatherapy for dementia

Emily Ball, Bethan Owen-Booth, Amy Gray, Susan Deborah Shenkin, Jonathan Hewitt, Jenny McCleery

Research output: Contribution to journalLiterature reviewpeer-review

Abstract / Description of output

Medications licensed for the treatment of dementia have limited efficacy against cognitive impairment or against the distressed behaviours (behavioural and psychological symptoms, or behaviour that challenges) which are also often the most distressing aspect of the disorder for caregivers. Complementary therapies, including aromatherapy, are attractive to patients, practitioners and families, because they are
perceived as being unlikely to cause adverse effects. Therefore there is interest in whether aromatherapy might offer a safe means of alleviating distressed behaviours in dementia.
Original languageEnglish
JournalCochrane Library
Publication statusPublished - 19 Aug 2020


Dive into the research topics of 'Aromatherapy for dementia'. Together they form a unique fingerprint.

Cite this